Electromed, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022
August 23, 2022 at 04:16 pm EDT
Share
Electromed, Inc. reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was USD 41.66 million compared to USD 35.76 million a year ago. Net income was USD 2.31 million compared to USD 2.36 million a year ago.
Basic earnings per share from continuing operations was USD 0.27 compared to USD 0.28 a year ago. Diluted earnings per share from continuing operations was USD 0.26 compared to USD 0.27 a year ago.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
ELECTROMED, INC. 
